Linc AB (OSTO:LINC) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Linc AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Linc AB's float shares is 0.00 Mil. Linc AB's total shares outstanding is 57.91 Mil. Linc AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Linc AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Linc AB's Institutional Ownership is 17.62%.

Linc AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Linc AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	0.00	/	57.91
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linc AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Linc AB (OSTO:LINC) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

6ZB:Germany

Address

Strandvagen 7A, Stockholm, SWE, 114 51

Website

https://www.linc.se

Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invests in and develops small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.